NG
NORTHROP GRUMMAN CORP /DE/ (NOC)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 delivered mixed headline results: revenue rose 4% YoY to $10.42B but came in below consensus, while EPS rose 10% YoY to $7.67 and beat Street expectations; segment OM expanded 80 bps to 12.3% as operational execution and favorable EACs supported profitability .
- Guidance was reset: FY25 sales lowered to $41.7–$41.9B (from $42.05–$42.25B), but MTM-adjusted EPS raised to $25.65–$26.05 (from $25.00–$25.40); free cash flow guidance held at $3.05–$3.35B .
- Operating cash and FCF inflected positively: Q3 operating cash flow of $1.56B and FCF of $1.26B (up 72% YoY) on higher earnings and improved trade working capital; book-to-bill was a strong 1.17 with $12.2B of net awards and $91.4B backlog .
- Key stock catalysts: clarity on B‑21 production acceleration, outcomes on FPXX, and international IBCS orders starting in 2026; near-term revenue timing/award delays tempered sales guide, but margin/FCF resilience and segment mix support EPS upside .
What Went Well and What Went Wrong
What Went Well
- Mission Systems drove profitability: OM rate expanded to 16.7% on efficiencies and a $68M favorable EAC in restricted advanced microelectronics, underpinning consolidated segment OM of 12.3% .
- Free cash flow strength: Q3 operating cash flow of $1.56B and FCF of $1.26B rose on improved working capital; company reaffirmed FY25 FCF $3.05–$3.35B .
- Strategic momentum and awards: Book-to-bill 1.17 with $12.2B net awards, including GMD Weapon System extension (~multi‑billion), and ongoing IBCS progress (32/32 successful flight tests) .
Quotes
- “Segment operating margin increased to 12.3% in Q3, which drove a 10% year‑over‑year increase in earnings per share.” – Kathy Warden .
- “We are increasing our [FY25 EPS] guidance by $0.65…driven by lower unallocated costs, modest pension/tax tailwinds and returns on marketable securities.” – CFO Ken Crews .
What Went Wrong
- Revenue timing/award delays: FY25 sales outlook cut to $41.7–$41.9B due to delayed timing and uncertain awards; Aeronautics sales guide reduced to “High $12B” from “Low $13B” .
- Space Systems headwinds: Q3 sales down 6% YoY on wind‑down of restricted space and NGI work and lower SDA volume; OM% declined to 11.0% .
- Higher ETR YoY: Q3 ETR rose to 16.9% (from 13.6%) due to 2024 reserve releases and lower 2025 research credits following OBBBA enactment .
Financial Results
Top-line, margins, EPS, and cash flow (oldest → newest)
Q3 2025 vs Wall Street consensus (SPGI)
Values retrieved from S&P Global*
Segment performance (Q3 2025)
KPIs (Q3 2025)
Guidance Changes
Why: Sales guide trimmed on award timing/uncertainty and intercompany mix; EPS lifted on lower unallocated corporate expense, modest pension/tax tailwinds, and marketable securities gains; FCF maintained with seasonal Q4 uplift drivers intact .
Earnings Call Themes & Trends
Management Commentary
- “We achieved mid‑single‑digit growth, expanded our segment operating margins, and grew free cash flow year over year…we remain on track to receive LRIP LOT 3 and LOT 5 advanced procurement awards later this year.” – Kathy Warden .
- “We are exploring creative ways to…incorporate AI into our solutions…and developing smarter weapon systems that bring unmatched superiority on the battlefield.” – Kathy Warden .
- “Segment operating margin rate increased 80 basis points to 12.3%…Mission Systems OM increased nearly 300 bps to 16.7% with a $68M favorable EAC in restricted advanced microelectronics.” – Ken Crews .
- “We are increasing [FY25] EPS guidance by $0.65…We are reaffirming free cash flow of $3.05B to $3.35B.” – Ken Crews .
Q&A Highlights
- B‑21 acceleration and FPXX: Company is in active discussions with the Air Force to accelerate B‑21 production (earlier production at zero margin; longer‑term return improvement), while FPXX would add development revenue, likely dilutive to near‑term EPS but accretive long term .
- Revenue timing: Sales guide cut reflects delayed timing on certain awards/programs and higher intercompany sales; MS sales raised on execution; DS OM guide raised to high‑10% .
- IBCS growth: Expect international orders to phase in from 2026; view IBCS as a double‑digit growth driver next year .
- Supply chain: Rare earths risk mitigated by two U.S. microelectronics foundries and allied sourcing; minimal impact expected if shutdown resolves soon .
- SRM capacity: Tactical SRM capacity more than doubled; additional facility underway; positioning for second‑source wins (e.g., SM‑6) .
Estimates Context
- Q3 vs consensus: Revenue $10.42B vs $10.71B* (miss), EPS $7.67 vs $6.46* (beat), EBITDA ~$1.76B* vs $1.53B* (beat). Drivers: MS outperformance (favorable microelectronics EAC), DS strength, mark‑to‑market gains on marketable securities, and modest pension/tax tailwinds; revenue constrained by Space wind‑downs and award timing .
- Prior quarters: Q2 revenue/EPS exceeded consensus, supported by DS and MS execution and training divestiture gain; Q1 EPS miss was driven by a B‑21 LRIP loss provision .
Values retrieved from S&P Global*
Key Takeaways for Investors
- Margin and FCF quality > top-line volatility: Despite revenue timing headwinds, NOC expanded segment OM and lifted EPS guide while reaffirming FCF—supportive for multiple resilience .
- Segment mix improving: MS margin expansion and DS execution offset Space wind‑downs; watch intercompany eliminations and AS ramp cadence into Q4 .
- Near‑term catalysts: B‑21 production acceleration framework, FPXX outcome, and incremental IBCS orders—positive optionality not embedded in 2026 outlook .
- International demand underpinning growth: 20–32% international growth cited; multi‑year opportunity set across air/missile defense and radars .
- Watch tax/pension mark‑to‑market and securities returns: Q3 included ~$80M returns on marketable securities; company did not assume full Q3 gains in FY guide, leaving room for variability .
- Execution focus: Management emphasized digital transformation and IRAD to drive affordability and returns—key to sustaining OM% in low‑to‑mid 11s for 2026 absent large EACs .
Additional details
- Q3 revenue +4% YoY; Diluted EPS +10% YoY; Segment OM +80 bps YoY .
- Q3 Space sales −6% YoY on restricted/NGI wind‑downs; CRS missions offset partially .
- Tax update: OBBBA changes (full expensing of R&D, bonus depreciation extension) affected 2025 ETR dynamics; Q3 ETR 16.9% .
Notes on non-GAAP
- FY25 EPS guidance references MTM‑adjusted EPS; per‑share impact of total net FAS/CAS pension adjustment in Q3 was $1.06 after‑tax .
Press releases
- 10/21/25 press release directed investors to the 8‑K furnished earnings release and webcast; no additional financial disclosures beyond the 8‑K .
(End of recap)